Medtronic stutters again in Q4; settles Edwards TAVI tussle
This article was originally published in Clinica
Executive Summary
Medtronic’s fourth-quarter revenues of $4.57bn fell slightly short of analyst expectations of $4.58bn, but adjusted earnings of $1.12 per share were in line.